Effect of Amphotericin B on Treatment of Chronic Rhinosinusitis: A Double-blind Randomized Clinical Trial

Youseﬁ, Jaleh; Akhavan, Asghar; Hoseini-Motlagh, Reza; Khosravi, Mohammad Hossein; Panahi, Yunes; Banaei-Boroujeni, Shahin

doi:10.5812/rijm.64550

Effect of Amphotericin B on Treatment of Chronic Rhinosinusitis: A Double-blind Randomized Clinical Trial

Authors

¹ Department of Otolaryngology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran

² Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran

³ Students’ Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran

⁴ Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran

⁵ International Otorhinolaryngology Research Association (IORA), Universal Scientific Education and Research Network (USERN), Tehran, IR Iran

10.5812/rijm.64550

Abstract

Background: Chronic rhinosinusitis (CRS) is the inflammation of paranasal sinus mucous membranes. Considering the influence of fungi on chronic rhinosinusitis and different results concerning the effect of Amphotericin B on improvement of this condition; this study aimed to determine the effect of topical Amphotericin B on improvement of the symptoms in patients with CRS.

Methods: In this double-blind randomized clinical trial, 80 patients with chronic rhinosinusitis who visited the allergy clinic of Baqiyatallah Hospital from June to October 2014 were randomly allocated to two groups; the first group received 10 cc topical lavage of Amphotericin B (5 cc each nostril for every 12 hours) and the second group received placebo for three months. Symptoms, nasal mucusa smear, serum level of inflammatory cytokines, CT scan and rhinoscopy score changes were evaluated in both groups after three months.

Results: Fifty-five male and 25 female patients were evaluated in two groups. The mean age was 26.1 2.36 and 27.9 1.59 years in intervention and control groups respectively (P = 0.08). There were no significant differences in demographic data between the groups (P > 0.05). Nasal obstruction, post nasal drip (PND), reduced sense of smell, quality of life, CT scan and rhinoscopy scores were not significantly different between the two groups after intervention (P > 0.05). Facial pain severity score was significantly more reduced in intervention group in comparison with control group (P < 0.01).

Conclusions: We concluded that application of Amphotericin B as an adjunctive medication to other common treatments, does not seem to be an efficient method for improvement of CRS symptoms.

Keywords

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

References

1.Krous JHCS, Gordon BR, Derebery MJ. Allergy and immunology. 17 ed. Philadelphia: Lippincott Williams and Wilkings; 2002. pp. 221-3.

2. Hsu J, Peters AT. Pathophysiology of chronic rhinosinusitis with nasal polyp. Am J Rhinol Allergy. 2011;25(5):285-90. [PubMed: 22186239]. https://doi.org/10.2500/ajra.2011.25.3680 PMid:22186239

3. Choi SSGK, Kennedy DW, Bolger WE, Zinreich SJ. Complications in sinus disease. 14 ed. London: B. C. Decker Inc; 2001.

4. Kern RC, Conley DB, Walsh W, Chandra R, Kato A, Tripathi-Peters A, et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol. 2008;22(6):549-59. [PubMed: 18786300]. https://doi.org/10.2500/ajr.2008.22.3228 PMid:18786300 PMCid:PMC2802263

5. National Center for Health Statistics. Summary health statistics for us adults, 1997, Data form the national health interview survey; 2002.

6. Kohatsu W. Complementary and alternative medicine secrets. Philadelphia: Hanley and Belfus; 2002.

7. Kennedy DW, Bolger WE, Zinreich SJ. Diseases of the sinuses, diagnosis and management. Canada: PMPH, USA; 2001.

8. Nuutinen J, Holopainen E, Haahtela T, Ruoppi P, Silvasti M. Balanced physiological saline in the treatment of chronic rhinitis. Rhinology. 1986;24(4):265-9. [PubMed: 3823748].

9. Rudert H, Maune S, Mahnke CG. [Complications of endonasal surgery of the paranasal sinuses. Incidence and strategies for prevention]. Laryngorhinootologie. 1997;76(4):200-15. [PubMed: 9264594]. https://doi.org/10.1055/s-2007-997414 PMid:9264594

10. May M, Levine HL, Mester SJ, Schaitkin B. Complications of endoscopic sinus surgery: analysis of 2108 patients-incidence and prevention. Laryngoscope. 1994;104(9):1080-3. [PubMed: 8072353]. https://doi.org/10.1288/00005537-199409000-00006 PMid:8072353

11. Levine HL. Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients. Laryngoscope. 1990;100(1):79-84. [PubMed: 2293704]. https://doi.org/10.1288/00005537-199001000-00016 PMid:2293704

12. Wackym PA, Rice DH, Schaefer SD. Minimally invasive surgery of the head, neck, and cranial base. Philadelphia: Lippincott Williams and Wilkins; 2002.

13. Rice DH, Schaefer SD, Calver LE. Endoscopic paranasal sinus surgery. Philadelphia: Lippincott Williams and Wilkins; 2004.

14. Hosemann W. Minimally invasive endonasal sinus surgery thieme. 1 ed. New York: Stuttgart; 2000.

15. Hamilos DL, Lund VJ. Etiology of chronic rhinosinusitis: the role of fungus. Ann Otol Rhinol Laryngol Suppl. 2004;193:27-31. [PubMed: 15174758]. https://doi.org/10.1177/00034894041130S508 PMid:15174758

16. Ponikau JU, Sherris DA. The role of airborne mold in chronic rhinosinusitis. J Allergy Clin Immunol. 2006;118(3):762-3. [PubMed: 16950303]. https://doi.org/10.1016/j.jaci.2006.06.035 PMid:16950303

17. Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol. 2004;114(6):1369-75. [PubMed: 15577837]. https://doi.org/10.1016/j.jaci.2004.08.012 PMid:15577837

18. Ponikau JU, Sherris DA, Kephart GM, Adolphson C, Kita H. The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol. 2006;30(3):187-94. https://doi.org/10.1385/CRIAI:30:3:187 PMid:16785589

19. Wildfeuer A, Seidl HP, Paule I, Haberreiter A. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses. 1998;41(7-8):309-19. [PubMed: 9861837]. https://doi.org/10.1111/j.1439-0507.1998.tb00344.x PMid:9861837

20. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005;115(1):125-31. [PubMed: 15637558]. https://doi.org/10.1016/j.jaci.2004.09.037 PMid:15637558

21. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006;118(5):1149-56. [PubMed: 17088142]. https://doi.org/10.1016/j.jaci.2006.07.058 PMid:17088142

22. Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS. Effect of anti fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol. 2002;116(4):261-3. [PubMed: 11945184]. https://doi.org/10.1258/0022215021910708 PMid:11945184

23. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31(4):183-4. [PubMed: 8140385].

24. Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2002;110(6):862-6. [PubMed: 12464951]. https://doi.org/10.1067/mai.2002.130051 PMid:12464951

25. Liang KL, Su MC, Shiao JY, Tseng HC, Hsin CH, Lin JF, et al. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, doubleblind study. Am J Rhinol. 2008;22(1):52-8. [PubMed: 18284860]. https://doi.org/10.2500/ajr.2008.22.3115 PMid:18284860

26. Shin SH, Ye MK. Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol. 2004;124(10):1174-7. [PubMed: 15768813]. https://doi.org/10.1080/00016480410017404 PMid:15768813

27. Ebbens FA, Georgalas C, Luiten S, van Drunen CM, Badia L, Scadding GK, et al. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope. 2009;119(2):401-8. [PubMed: 19160404]. https://doi.org/10.1002/lary.20064 PMid:19160404

28. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004;113(6):1122-8. [PubMed: 15208594]. https://doi.org/10.1016/j.jaci.2004.03.038 PMid:15208594

29. Helbling A, Baumann A, Hanni C, Caversaccio M. Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol. 2006;120(12):1023-5. [PubMed: 16965642]. https://doi.org/10.1017/S0022215106002167 PMid:16965642

30. Gerlinger I, Fittler A, Fonai F, Patzko A, Mayer A, Botz L. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch Otorhinolaryngol. 2009;266(6):847-55. [PubMed: 18953552]. https://doi.org/10.1007/s00405-008-0836-0 PMid:18953552

Razavi International Journal of Medicine

Effect of Amphotericin B on Treatment of Chronic Rhinosinusitis: A Double-blind Randomized Clinical Trial

References

Volume 5, Issue 4
October 2017

Files

Share

How to cite

Statistics

Effect of Amphotericin B on Treatment of Chronic Rhinosinusitis: A Double-blind Randomized Clinical Trial

References

Volume 5, Issue 4October 2017

Files

Share

How to cite

Statistics

Volume 5, Issue 4
October 2017